Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
2017 · The Lancet Oncology · 1,151 citations
https://doi.org/10.1016/s1470-2045(17)30441-2